Bone Marrow Stromal Cell Transplants Prevent Experimental Enterocolitis and Require Host CD11b+ Splenocytes
Open Access
- 1 March 2011
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 140 (3) , 966-975.e4
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Development of Monocytes, Macrophages, and Dendritic CellsScience, 2010
- Overview of biologic therapy for Crohn's diseaseExpert Opinion on Biological Therapy, 2009
- Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cellsThe Lancet, 2004
- Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influencesGastroenterology, 2004
- Veto-Like Activity of Mesenchymal Stem Cells: Functional Discrimination Between Cellular Responses to Alloantigens and Recall AntigensThe Journal of Immunology, 2003
- Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primatesBlood, 2003
- Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantationTransplantation, 2003
- Mesenchymal Stem Cells Inhibit and Stimulate Mixed Lymphocyte Cultures and Mitogenic Responses Independently of the Major Histocompatibility ComplexScandinavian Journal of Immunology, 2003
- Curcumin prevents and ameliorates trinitrobenzene sulfonic acid–induced colitis in miceGastroenterology, 2002
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2002